Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation

Moda-Sava, R. N., Murdock, M. H., Parekh, P. K., Fetcho, R. N., Huang, B. S., Huynh, T. N., Witztum, J., Shaver, D. C., Rosenthal, D. L., Alway, E. J., Lopez, K., Meng, Y., Nellissen, L., Grosenick, L., Milner, T. A., Deisseroth, K., Bito, H., Kasai, H., Liston, C.·2019·Science
DOI 10.1126/science.aat8078

Cited by (644)

Items 501–600 of 644

  1. Dissoziation bei Mensch und Maus
    Manfred Spitzer · 2020 · Nervenheilkunde
  2. Ketamine’s pharmacogenomic network in human brain contains sub-networks associated with glutamate neurotransmission and with neuroplasticity
    Gerald A. Higgins, Samuel A. Handelman, Ari Allyn-Feuer, Alex S. Ade, James S. Burns, Gilbert S. Omenn, Brian D. Athey · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Astrocytes derived from ASD patients alter behavior and destabilize neuronal activity through aberrant Ca 2+ signaling
    Megan Allen, Ben S. Huang, Michael J. Notaras, Aiman Lodhi, Estíbaliz Barrio-Alonso, Paul Wolujewicz, Jonathan Witztum, Francesco Longo, Maoshan Chen, David W. Greening et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  4. Plasticity in the Adult Brain
    Blake J. Laham, Elizabeth Gould · 2020 · Elsevier eBooks
  5. Ketamine-Induced Unresponsiveness Shows a Harmonic Shift from Global to Localised Functional Organisation
    Milan Van Maldegem, Jakub Vohryzek, Selen Atasoy, Naji Alnagger, Paolo Cardone, Vincent Luce Bonhomme, Audrey Vanhaudenhuyse, Athena Demertzi A, Océane Jaquet, Mohamed Ali Bahri et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  6. Quantitative monitoring of ketamine’s impact on synaptic density using 11C-UCB-J PET imaging in the corticosterone mouse model of anxiety/depression
    Corvo, Cassandre, Goutal, Sébastien, Mendez-David, Indira, Leterrier, Sarah, Caille, Fabien, Saba, Wadad, Colle, Romain, Corruble, Emmanuelle, Lebon, Vincent, Bottlaender, Michel et al. · 2026 · Molecular Psychiatry
  7. Proteomic characterization of the medial prefrontal cortex in chronic restraint stress mice
    Yufeng Fu, Zhongya Gu, Huấn Cao, Chengchao Zuo, Yaqi Huang, Yu Song, Jinfeng Miao, Yongsheng Jiang, Furong Wang · 2024 · Journal of Proteomics
  8. KETAMINE: Neural- and network-level changes
    Vishal Bharmauria, Hamidreza Ramezanpour, Afef Ouelhazi, Yahia Yassine Belkacemi, Oliver E. Flouty, Stéphane Molotchnikoff · 2024 · Neuroscience
  9. Simulated synapse loss induces depression-like behaviors in deep reinforcement learning
    Eric Chalmers, Santina Duarte, Xena Al-Hejji, Daniel J. A. Devoe, Aaron J. Gruber, Robert J. McDonald · 2024 · Frontiers in Computational Neuroscience
  10. Single‐Nucleus RNA Sequencing Reveals That Gabra6 + Neurons in Prefrontal Cortex Promote the Progression of PTSD After Shockwave‐Induced TBI
    Xiaowei Fei, Zehan Zhang, Yanan Dou, Weihao Lv, Hongqing Chen, Li Wang, Xin He, Wangshu Chao, Peng Luo, Zhou Fei · 2024 · Advanced Science
  11. Illuminating the impact of stress: In vivo approaches to track stress-related neural adaptations
    Puja K. Parekh · 2025 · Neurobiology of Stress
  12. Synapses mediate the effects of different types of stress on working memory: a brain-inspired spiking neural network study
    Chengcheng Du, Yinqian Sun, Jihang Wang, Qian Zhang, Yi Zeng · 2025 · Frontiers in Cellular Neuroscience
  13. Functional connectivity alterations of the pregenual anterior cingulate cortex by ketamine and the modulation by lamotrigine
    David Weigner, Marvin Sören Meiering, Anne Weigand, Luisa Carstens, Christian Keicher, Rita Hertrampf, Christian F. Beckmann, Maarten Mennes, Andreas Wunder, Matti Gärtner et al. · 2025 · Journal of Psychopharmacology
  14. Combinatorial targeting of NMDARs and 5-HT4Rs exerts beneficial effects in a mouse model of Alzheimer’s disease
    Briana K. Chen, Holly C. Hunsberger, A. Whye, Louise C. Matthews, Alyson Yook, Moshe J. Willner, R. Logan, Stefanie Johns, Eric Weisblum, C. Denny · 2025 · Alzheimer's Research & Therapy
  15. Advancing depression treatment: the role of sigma receptor ligands
    Peng Zhang, Zeqiong Ning, Haixia Chen, Jia Chen, Zhihong Lu, Feifei Xu · 2025 · Frontiers in Neuroscience
  16. Astrocytic PERK Deficiency Drives Prefrontal Circuit Dysfunction and Depressive‐Like Behaviors
    Kai Chen, Riya Gupta, Yosuke M. Morizawa, Yu Qin, Xingyu Du, C. Hor-Nay Pang, Osama Al‐Dalahmah, Maura B. Dupont, Guang Yang · 2025 · Advanced Science
  17. Transcriptional Signatures of Mitochondrial Metabolism Predict Esketamine-Induced rACC Structural Changes in Adolescent Major Depression
    Yanling Zhou, Weicheng Li, Xiaofeng Lan, Chengyu Wang, Xiaoyu Chen, Zhanjie Luo, Fan Zhang, Guanxi Liu, Zitao Wu, Junhao Shen et al. · 2025 · Journal of the American Academy of Child & Adolescent Psychiatry
  18. Cannabidiol Alleviates LPS-Induced Depressive-Like Behaviors Via Improving Mitochondria Function
    Junning Zhao, Qian Liu, Xin Wang, Yusen Xiao, Baiyi Yao, Jiale Liu, Cailin Wang, Gongping Liu, Xiaoyue Hong · 2026 · Molecular Neurobiology
  19. Exploring new rehabilitation pathways for stroke based on the comorbidity of post-stroke hypoesthesia with anxiety and depression
    Yuyan Chen, Yusheng Zhao, Bangqi Wu, Yupei Cheng, Huang Jingjie, Chaoran Wang, Bai Jing, Yuxing Zhang · 2026 · PeerJ
  20. De Novo Generation-Based Design of Potential Computational Hits Targeting the GluN1-GluN2A Receptor
    Yibo Liu, Zhijiang Yang, Yixuan Guo, Tengxin Huang, Li Pan, Junjie Ding, Weifu Dong · 2026 · Molecules
  21. Running exercise attenuates excitatory synaptic loss in the medial prefrontal cortex of CUS rats: Potential modulation of microglial and astrocytic synaptic contacts
    Xingyu Wu, Shan Liu, Qian Xiao, Jing Tang, Hui-Fang Luo, Xin-yan Ren, Lin Jiang, Xin Liang, Dujuan Huang, Chunni Zhou et al. · 2026 · Neuropharmacology
  22. Ketamine for negative and depressive symptoms in schizophrenia: the evidence so far
    Cornelia Diendorfer, C. Bum, Ana Weidenauer, Ulrich Sauerzopf, Lucie Bartova, Irena Dajic, L. Müller, Dan Rujescu, Nicole Praschak-Rieder, Matthäus Willeit · 2026 · Frontiers in Psychiatry
  23. Ketamine as a Rapid-Acting Antidepressant: A Scoping Review of Mechanisms and Efficacy in Treatment-Resistant Depression
    Xiao-Ran Ding, Ya-Ping Wu, Juan Yang, Guo-Hui Zhu, Hong-Wei Sun · 2026 · Psychopathology
  24. Astrocytes in the Circadian System: A Promising Target for Mood Disorder Interventions
    Peijie Liu, Hongguo Li, Yuchen Zhu, Siqi Song, Liang Kang, Yushi Hu · 2026 · Journal of Integrative Neuroscience
  25. Esketamine Nasal Spray: Mechanism of Action, Clinical, and Translational Science
    Matthijs W. van Hoogdalem, Dong‐Jing Fu, Wayne Curtis Drevets, Peter Zannikos · 2026 · Clinical and Translational Science
  26. The Emerging Neurobiology of Psychedelics: Critical Periods, Metaplasticity, and Extracellular Matrix Remodeling
    Gül Dölen, Makenzie L. Wilkinson · 2026 · Annual Review of Neuroscience
  27. R -MDDMA is a Safer Analogue of MDMA with Therapeutic Potential
    Maxemiliano V. Vargas, Cassandra J. Hatzipantelis, Lee E. Dunlap, Robert J. Tombari, Arabo A. Avanes, Sam Vaillancourt, Pierre Llorach, Juliana S. Salgado, Boris Dov Heifets, David E. Olson · 2026 · ACS Chemical Neuroscience
  28. From synapse to strategy: a bibliometric map of ionotropic glutamate receptors in depression
    Yunsheng Liu, Rongde Zhong, Fenyong Yao, Huafu Zhao, Yuyan Wang, Changjian Li, Jinfang Zhang, Zengwei Kou · 2026 · Naunyn-Schmiedeberg s Archives of Pharmacology
  29. Synthesis of Clausenamide Isomers and Evaluation of Their Potential as Cortical Neuroplastogens
    Yongyu Ou, Yara A. Khatib, Adam Mosswood, Tarun K. Roy, David A. Gutierrez, David E. Olson, Jared T. Shaw · 2026 · ACS Chemical Neuroscience
  30. Microbiota-Derived SCFAs Mediate the Synergistic Antidepressant Effects of Dajianzhong Decoction and Ketamine via FFAR2-NLRP3-IL-1β Signaling
    Wenting Zhang, Xin Guo, Jiping Zhang, Yuan‐Wei Zhang, Chan Li · 2026 · Pharmaceuticals
  31. Distinctive Molecular Mechanisms in Higher Cortical Circuits Confer Vulnerability to Mental Disorders
    Min Wang, Veronica C. Galvin, Mary Kate P. Joyce, Dibyadeep Datta, Shengtao Yang, Anita A. Disney, Amy F.T. Arnsten · 2026 · Biological Psychiatry
  32. Depression in neurodegenerative disease: neurobiological mechanisms and emerging treatments
    Harry Costello, Suzanne Reeves, Paul Glue, Allan Hunter Young, Robert J. Howard · 2026 · Molecular Psychiatry
  33. Social hierarchy shapes behavioral and transcriptional responses to chronic stress and ketamine in male mice
    Serena Gasperoni, Xiuqi Ji, Choham Sudre-Chinsky, Eduardo Cáceres Pajuelo, Fatemeh Sadat Zolfaghari, O. Boldemann, Manar Manla Hasan, Tommaso Biagini, Daniil Umanski, Yair Shemesh et al. · 2026 · iScience
  34. Dorsolateral Prefrontal Cortex Circuitry at the Intersection of Cognition and Disease
    Dibyadeep Datta, Amy F.T. Arnsten, Stacey J. Sukoff Rizzo, Afonso C. Silva, Mary Kate P. Joyce, Shreejoy J. Tripathy, Angela Roberts, David A. Lewis · 2026 · Biological Psychiatry
  35. FGF13 exerts neuroprotective effects via activation of the PI3K/AKT signaling pathway and serves as a potential biomarker for depression
    Haitao Hu, Juan Lu, Xin Du, Peng Ge, Mengxue Fu, Tongshuai Pan, Lili Yuan, Yuanxiang Zhang, Yigao Wu, Jiucui Tong · 2026 · Biochemical and Biophysical Research Communications
  36. Bringing in the ACE(i): Angiotensin-Converting Enzyme Inhibitors as Antidepressants
    Brendan D. Hare, Ralph Dileone · 2020 · Biological Psychiatry
  37. Esketamine: the first glutamatergic drug for the management of treatment- resistant depression
    Laura Musazzi · 2020
  38. Cortical Plasticity under Ketamine: From Synapse to Map
    Afef Ouelhazi, Rudy Lussiez, Stéphane Molotchnikoff · 2022 · IntechOpen eBooks
  39. Synapses, predictions, and prediction errors: A neocortical computational study of MDD using the temporal memory algorithm of HTM
    Mohamed A. Sherif, Mostafa Khalil, Rammohan Shukla, Joshua C. Brown, Linda L. Carpenter · 2023 · Frontiers in Psychiatry
  40. Kétamine et suicidalité : modèles animaux pour comprendre son mécanisme d’action
    Thi Mai Loan Nguyen, Fabrice Jollant, Laurent Tritschler, Romain Colle, Emmanuelle Corruble, Alain Michel Gardier · 2023 · Annales Pharmaceutiques Françaises
  41. Coeloglossum viride var. bracteatum attenuates lipopolysaccharide-induced acute depressive-like behaviors in mice by inhibiting neuroinflammation and protecting synaptic plasticity
    Zhe Guo, Jin-Peng Bai, Jun Wang, Xiu-Yuan Lang, Minmin Cao, Si-Jia Zhong, Liang Cui, Yang Hu, Xiao‐Yan Qin, Rongfeng Lan · 2024 · Journal of Functional Foods
  42. A Narrative Review: The Role that Ketamine May Play in the Treatment of Depression and the Underlying Mechanisms of Its Effect
    Sophie Höfels · 2025 · BILT Student Research Journal 2025 - Issue 6
  43. mGlu2/3 Receptor Antagonists as Rapid-Acting Antidepressants
    Shigeyuki Chaki · 2021 · Contemporary clinical neuroscience
  44. Ketamine for depression – evidence and proposals for practice
    Tor-Morten Kvam, Lowan Han Stewart, Andreas Wahl Blomkvist, Ole A. Andreassen · 2021 · Tidsskrift for Den norske legeforening
  45. Involvement of PKMζ in Stress Response and Depression
    Jianfeng Liu · 2022 · Frontiers in Cellular Neuroscience
  46. Utility and Implementation of Oral Corticosteroid Exposure in Behavioral Neuroscience Research with Rodents
    Michelle K. Sequeira, Jane R. Taylor, Shannon L. Gourley · 2022 · Neuromethods
  47. Exploring the Mechanism of Action of Trachelospermi Caulis et Folium for Depression Based on Experiments: Combining Network Pharmacology and Molecular Docking
    Lingmiao Wen, Yuqing Fan, Wei Xiong, Yanjun Liu, Tinglan Zhang, Guihua Wei, Alvin M. Altamirano, Tiane Zhang, Zhiyong Yan · 2022 · Computational and Mathematical Methods in Medicine
  48. Drug self-administration in head-restrained mice for simultaneous multiphoton imaging
    Kelsey M. Vollmer, Elizabeth M. Doncheck, Roger I. Grant, Kion T. Winston, Elizaveta V Romanova, Christopher W Bowen, Preston N. Siegler, Ana‐Clara Bobadilla, Ivan Trujillo‐Pisanty, Peter W. Kalivas et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  49. Aberrant structural synaptic dynamics precede disorganization of temporal and spatial coding in the hippocampus upon repeated stress exposure
    Alireza Chenani, Ghabiba Weston, A.F. Ulivi, Tim P. Castello-Waldow, Alon Chen, Alessio Attardo · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Neurogenesis mediated plasticity is associated with reduced neuronal activity in CA1 during context fear memory retrieval
    Alexandria Evans, Dylan J. Terstege, Gavin A. Scott, Mio Tsutsui, Jonathan R. Epp · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  51. Impaired glutamate reuptake induces synaptic mistuning in rat hippocampal slices, that can be counteracted by ketamine
    Erika Vázquez‐Juárez, Ipsit Srivastava, Maria Lindskog · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  52. The molecular fingerprint of stress resilience
    Jakub Włodarczyk, Ewa Bączyńska, Monika Zaręba-Kozioł, Błażej Ruszczycki, Adam Krzystyniak, Tomasz Wójtowicz, Krystian Bijata, Bartłomiej Pochwat, Marta Magnowska, Matylda Roszkowska et al. · 2022 · Research Square
  53. Heterogeneous complement and microglia activation mediates stress-induced synapse loss
    Breeanne M. Soteros, Haven Tillmon, Mackenna Wollet, Julianne General, Hanna Chin, John Beichen Lee, Flavia Regina Carreno, David A. Morilak, Jun Hee Kim, Gek-Ming Sia · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  54. Ketamine potentiates a central glutamatergic presynapse
    Abdelmoneim Eshra, Noa Lipstein, Stefan Hallermann · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Nitrous Oxide activates layer 5 prefrontal cortical neurons via SK2 channel inhibition for antidepressant effect
    Joseph Cichon, Thomas T. Joseph, Andrzej Z. Wasilczuk, Daniel Markman, Max B. Kelz, Peter Nägele · 2024 · Research Square
  56. Opioid receptor expressing neurons of the central amygdala gate behavioral effects of ketamine in mice
    Matthew B. Pomrenze, Sam Vaillancourt, Pierre Llorach, Daniel Ryskamp Rijsketic, Austen B. Casey, Nicholas Scott Gregory, Juliana S. Salgado, Robert C. Malenka, Boris Dov Heifets · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Downregulation of AdipoR1 in the hippocampus impairs synaptic function and structure and causes depression-like behavior
    Yong Cheng Tang, Peilin Zhu, Yanmin Luo, Yue Li, Jing Tang, Li Liu, Yuhui Deng, Jing Li, Lin Hong Jiang, Wenyu Yang et al. · 2024 · Research Square
  58. Negative allosteric modulation of α5-GABA A receptors engages dynamic cortical glutamatergic and GABAergic mechanisms underlying adaptive behavior in mice
    Fernanda Daher, Caio Tabata Fukushima, Erik A. Ingebretsen, Jean M. Bidlack, John R. Atack, M. Oana Popa, Manoela V. Fogaça · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
    Tanaka, Masaru · 2026 · Biomedicines
  60. Novel Treatment Strategies for Major Depressive Disorder: Investigating Ketamine’s Antidepressant Effects and the Role of the c-Jun N-Terminal Kinase Pathway
    Melanie Clarke · 2019 · Carleton University's Institutional Repository (MacOdrum Library, Carleton University)
  61. Hypnose, activation de conscience et nouvelles solutions thérapeutiques des addictions : aspects neurobiologiques
    Bruno Suárez · 2019 · Psychotropes
  62. Ketamine's potential mechanism of action for rapid antidepressive effects – a focus on neuroplasticity
    Melody J.Y. Kang · 2020 · Elsevier eBooks
  63. Ketamine prolongs survival in symptomatic SOD1-G93A mice
    John A. Stanford, Matthew Macaluso, Richard J. Barohn, Lauren Peck · 2021 · RRNMF Neuromuscular Journal
  64. Rifaximin-Mediated Gut Microbiota Regulation Modulates the Polarization of Microglia During CUMS in Rat
    Haonan Li, Yujiao Xiang, Zemeng Zhu, Wei Wang, Zhijun Jiang, Mingyue Zhao, Shuyue Cheng, Fang Pan, Dexiang Liu, Roger Ho et al. · 2021 · Research Square
  65. Physiological basis underlying antidepressant-induced activation of TrkB receptors
    Okko Alitalo, Samuel Kohtala, Marko Rosenholm, Piia Kohtala, Roosa Saarreharju, Nobuaki Matsui, Gemma González-Hernández, Heidi Kaastrup Müller, Wiebke Theilmann, Mirkka P. Sarparanta et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Effects of Intranasal (S)-Ketamine on Veterans With Co-Morbid Treatment-Resistant Depression and PTSD
    Hewa Artin, Sean Bentley, Eamonn Mehaffey, Fred X. Liu, Kevin Sojourner, Andrew W. Bismark, DAVID J. PRINTZ, Ellen Lee, Brian Martis, Sharon De Peralta et al. · 2021 · SSRN Electronic Journal
  67. A cortical hierarchy for differential GABAergic circuit motifs as targets for stress-induced alterations in endocannabinoid signaling
    Karl-Alexander Engelhardt · 2021
  68. Lasting restoration
    Natasha Bray · 2019 · Nature reviews. Neuroscience
  69. Faculty Opinions recommendation of Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.
    David A. Morilak · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  70. Faculty Opinions recommendation of Deep posteromedial cortical rhythm in dissociation.
    Edward Zagha · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  71. Antidepressant Drugs
    Flavia Regina Carreno, Alan Frazer · 2021 · Elsevier eBooks
  72. Mood Disorders and Depression
    Harald W. Sontheimer · 2021 · Elsevier eBooks
  73. Ketamine Promotes Adaption-Induced Orientation Plasticity and Vigorous Network
    Afef Ouelhazi, Afef Ouelhazi, Rudy Lussiez, Stéphane Molotchnikoff · 2022 · SSRN Electronic Journal
  74. Neural circuit mechanisms of rapid antidepressant actions of ketamine
    Ryota Shinohara · 2022 · Folia Pharmacologica Japonica
  75. Effects of nitrous oxide and ketamine on the prefrontal cortex in mice: a comparative study
    Stanislav V. Rozov, Roosa Saarreharju, Stanislav Khirug, Markus Storvik, Claudio Rivera, Tomi Rantamäki · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  76. A novel antidepressant acting via allosteric inhibition of GluN2D-incorporated NMDA receptors at GABAergic interneurons
    Jilin Zhang, Jinjin Duan, Luyu Ye, Wei Li, Haitao Zhou, Fang Liu, Tian Xiaoting, Yang Xie, Yiming Huang, Yidi Sun et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Basolateral amygdala circuits supporting negative emotional bias in a mouse model for depression
    Mathilde Bigot, Claire-Hélène De Badts, Axel Benchetrit, Éléonore Vicq, Carine Moigneu, Manon Meyrel, Sébastien Wagner, Josselin Houenou, Pierre‐Marie Lledo, Chantal Henry et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Visualizing drug actions on dendrites: psilocybin and other classic psychedelics
    Ling-Xiao Shao, Clara Liao, Ian Gregg, Pasha A. Davoudian, Neil K. Savalia, Kristina Delagarza, Alex C. Kwan · 2023 · Optics in the Life Sciences
  79. Neurobiological Foundations of Psychiatry: Overview
    Tadafumi Kato · 2023 · Springer eBooks
  80. (R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice
    Atsushi Kasai, Rei Yokoyama, Yukio Ago, Hisato Igarashi, Momoko Higuchi, Masato Tanuma, Yuto Shimazaki, Kaoru Seiriki, Misuzu Hayashida, Shun Yamaguchi et al. · 2023 · Research Square
  81. Ketamin har god effekt mot depresjon
    Christine Marie Hasle Åman, Tor-Morten Kvam, Ole A. Andreassen, Andrea Charlotte Rønsen · 2023 · Sykepleien Forskning
  82. ANALYSIS OF THE ANTIDEPRESSANT POTENTIAL OF PHYSICAL EXERCISE PRACTICE, MEDIATED BY NEUROPLASTICITY, IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SYSTEMATIC REVIEW ARTICLE
    Leonardo Carrijo Naves, Luan Alves Marques de Melo, Lucas Damião Anjos, Luis Fernando Rodrigues Assunção · 2023 · International Journal of Health Science
  83. The Role of Rapid-Acting Antidepressants in Suicidal Crisis Management
    Aistė Lengvenytė, Marco Sarchiapone, Miriam Iosue, Philippe Courtet · 2024 · Cambridge University Press eBooks
  84. Unveiling the Neuroscientific Underpinnings of Mood and Anxiety Disorders
    Institut Pasteur, Université Paris Cité, CNRS UMR-3571, Perception and Memory Unit, F-75015 Paris, France, Pierre‐Marie Lledo · 2023 · Annals of Depression and Anxiety
  85. A melancholy machine: simulated synapse loss induces depression-like behaviors in deep reinforcement learning
    Eric Chalmers, Santina Duarte, Xena Al-Hejji, Daniel J. A. Devoe, Aaron J. Gruber, Robert J. McDonald · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Ketamine, Dissociation, and Depression: What Is “Special” About Ketamine? (Revisited)
    Mina Rizk, James W. Murrough · 2024 · The International Journal of Neuropsychopharmacology
  87. Do Molecular Interventions (Ketamine) Re-establish Synapses in Affected Brain Structures?
    Maxwell R. Bennett · 2024 · Springer eBooks
  88. Neurobiological Foundations of Psychiatry: Overview
    Tadafumi Kato · 2024 · Springer eBooks
  89. Nitrous Oxide activates layer 5 prefrontal neurons via SK2 channel inhibition for antidepressant effect
    Joseph Cichon, Thomas T. Joseph, Xinguo Lu, Andrzej Z. Wasilczuk, Max B. Kelz, Steven J. Mennerick, Charles F. Zorumski, Peter Nägele · 2024 · Research Square
  90. Astrocyte-derived extracellular matrix proteins regulate synapse remodeling in stress-induced depression
    Ran Zhang, Patricia Rodriguez‐Rodriguez, Lucian Medrihan, Jerry C. Chang, Tatiana Ferraro, Pedro Del Cioppo Vasques, Wei Wang, Caroline Ménard, Flurin Cathomas, Kenny L. Chan et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Current Treatments for Depression
    Maurizio Fava M. D, John Harrison Krystal · 2025 · Oxford University Press eBooks
  92. Neurotrophic Mechanisms of Depression and Antidepressant Action in Animal and Human Studies
    Lisa M. Monteggia · 2025
  93. Endoplasmic reticulum stress protein GRP78 for ketamine’s antidepressant effects
    Wanpeng Cui, Chen Shen, Wen‐Cheng Xiong, Lin Mei · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Glutamatergic Changes Induced by Stress in the Brain and Effects of Rapid-Acting Antidepressants
    Jessica Mingardi, Laura Musazzi · 2024 · Springer eBooks
  95. Application Progress of Esketamine in Non-Endotracheal Intubation General Anesthesia Surgery
    欣悦 王 · 2025 · Advances in Clinical Medicine
  96. Microglial brain-derived neurotrophic factor (BDNF) supports the behavioral and synaptogenic effects of ketamine
    Samuel C. Woodburn, Alexander M. Kuhn, Kelly E Bosis, David T. Dadosky, Etienne J. Mueller, Justin L. Bollinger, Rosa Maria Salazar Gonzalez, J. Elliott Robinson, Lauren Larke Vollmer, Eric S. Wohleb · 2026 · Brain Behavior and Immunity
  97. Jinwei Sinisan Alleviates Depression-Like Behaviors in Cums Mice by Regulating Synaptic Plasticity Through Pld2 Pathway
    Zedan Xie, Mengxue Chen, Wenjing Yi, Shanshan Wang, DI DENG, Lin An, Jinlan Zhao, Shasha Bai, Lei Yang, Yafei Shi et al. · 2025 · SSRN Electronic Journal
  98. A reciprocal interplay between 5-HT 2A and mGlu 5 receptors underlies neuroplasticity
    Tomas del Olmo, Mathilde Decourcelle, Martial Sevéno, Joël Bockaert, Philippe Marin, Carine Bécamel · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Glutamatergic Changes Induced by Stress in the Brain and Effects of Rapid-Acting Antidepressants
    Jessica Mingardi, Laura Musazzi · 2025 · Springer eBooks
  100. Preserved synaptic architecture but impaired ketamine-induced synaptic plasticity of layer 5 pyramidal neurons in the aged frontal cortex
    Irene F. Ugidos, JC Iglesias, Sebastian Milanes, Fatemeh Farahani, Ricardo Mostany · 2025 · bioRxiv (Cold Spring Harbor Laboratory)